TrialHIV medicine2018

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials.

D Hagins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.